Ultralife Corporation
ULBI
$7.44
$0.223.05%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 187.24M | 187.86M | 191.16M | 186.53M | 178.85M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 187.24M | 187.86M | 191.16M | 186.53M | 178.85M |
| Cost of Revenue | 141.59M | 144.47M | 145.08M | 141.91M | 135.17M |
| Gross Profit | 45.65M | 43.39M | 46.08M | 44.62M | 43.69M |
| SG&A Expenses | 26.43M | 26.81M | 27.04M | 26.17M | 24.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 179.88M | 182.24M | 182.52M | 178.07M | 169.27M |
| Operating Income | 7.36M | 5.62M | 8.64M | 8.46M | 9.58M |
| Income Before Tax | -9.63M | -11.51M | -8.40M | 2.30M | 4.41M |
| Income Tax Expenses | -2.98M | -3.21M | -2.45M | 568.00K | 1.15M |
| Earnings from Continuing Operations | -6.65 | -8.30 | -5.95 | 1.74 | 3.26 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 103.00K | 87.00K | 53.00K | -17.00K | -65.00K |
| Net Income | -6.55M | -8.21M | -5.90M | 1.72M | 3.20M |
| EBIT | 7.36M | 5.62M | 8.64M | 8.46M | 9.58M |
| EBITDA | 12.73M | 11.09M | 14.14M | 13.83M | 14.53M |
| EPS Basic | -0.39 | -0.49 | -0.35 | 0.10 | 0.19 |
| Normalized Basic EPS | 0.23 | 0.14 | 0.23 | 0.17 | 0.23 |
| EPS Diluted | -0.40 | -0.50 | -0.36 | 0.10 | 0.19 |
| Normalized Diluted EPS | 0.23 | 0.14 | 0.23 | 0.17 | 0.23 |
| Average Basic Shares Outstanding | 66.62M | 66.59M | 66.57M | 66.54M | 66.52M |
| Average Diluted Shares Outstanding | 66.67M | 66.61M | 66.64M | 66.74M | 66.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |